DIagnostic products
Precision drugs

Diagnostic tests that analyse stromal biomarkers, to diagnose and prognose tumor invasiveness

Novel stroma-targeted precision drugs, to fight against invasive tumors

Diagnostics tests that analyse stromal biomarkers

DIAGNOSTICS

Novel stroma-targeted precision drugs

PRECISION DRUGS

INVASIVE CANCER DIAGNOSTICS

ONCOMATRYX scientists have discovered and validated novel stromal biomarkers for accurate diagnosis and prognosis of invasive tumors.

col11A1en
bot-invas
bot_bladder
careers
Send your application

Join our team in BOSTON or BILBAO.

BLOG. Last ONCOMATRYX team posts, news and releases

  • war on cancer stroma

    “I declare war on cancer stroma”

    LAUREANO SIMON, Oncomatryx CEO, declares war on tumor microenvironment. “We envysion a new era where cancer in general and invasive tumors in particular will be beaten with orchestrated combinations of precision
  • Bio Europe Spring Amsterdam 2018

    Oncomatryx at BIO EUROPE SPRING 2018

    Oncomatryx will attend BIO EUROPE SPRING 2018, the essential appointment in biotechnology BIO EUROPE SPRING 2018 March 12-14, 2018 Amsterdam, The Netherlands https://ebdgroup.knect365.com/bioeurope- If you are also attending this event and you would like
    Read more